BioCentury
ARTICLE | Clinical News

Naloxone Hydrochloride Nasal Spray regulatory update

February 24, 2017 2:19 AM UTC

EMA accepted for review an MAA from Adapt for Naloxone Hydrochloride Nasal Spray to treat opioid overdose. Adapt markets the opioid antagonist nasal spray in the U.S. as Narcan Nasal Spray. Adapt has ...